Drawing for OSCILLOPHORESIS

USPTO serial 76702811

OSCILLOPHORESIS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MANOR, THOMAS M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OSCILLOPHORESIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William L Paradice III

William L Paradice III Mahamedi Paradice Kreisman LLP550 S. Winchester Boulevard,Ste. 605San Jose, CA 95128

Goods and services

ClassDescriptionStatusFirst use
005Biological, chemical, therapeutic and diagnostic preparations for medical purposes, namely, transdermal and dermatological preparations, reagents and pharmaceuticals and kits made therefrom for use in treatment of micro nutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; pharmaceutical preparations for use in treatment of micro nutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; drug delivery agents in the form of capsule, coating, tablet, or powder containing compounds that facilitate delivery and release of a wide range of pharmaceuticals and therapeutic agents; pharmaceuticals for use in treatment of micro nutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; therapeutic preparations for use in treatment of micro nutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disordersACTIVE—
010Therapeutic apparatus, namely, transdermal and dermatological apparatus, for diagnosing, treating, preventing and improving disease, disorder or condition and for use in the treatment of micro nutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders;medical devices for the purposes of treating micro nutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; medical and surgical implants for the purposes of treating micro nutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; drug delivery systems for the purposes of treating micro nutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; medical instruments for the purposes of treating micro nutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 25, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 25, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 23, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 21, 2012EX1GSOU EXTENSION 1 GRANTED—
Aug 21, 2012EXT1SOU EXTENSION 1 FILED—
Aug 21, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 11, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 11, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 21, 2012NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 27, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 7, 2011NPUBNOTICE OF PUBLICATION—
Nov 23, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 23, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2011ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 21, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 21, 2011MAILPAPER RECEIVED—
Apr 19, 2011CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 19, 2011CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 30, 2011ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 30, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 3, 2011ALIEASSIGNED TO LIE—
Mar 1, 2011MAILPAPER RECEIVED—
Aug 25, 2010CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2010DOCKASSIGNED TO EXAMINER—
May 14, 2010MAFRAPPLICATION FILING RECEIPT MAILED—
May 10, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance